| 摘要 |
The present invention features automated devices, kits, and assay methods for measuring glycosaminoglycan levels in body fluids such as urinary glycosaminoglycan excretion or blood heparin levels. Such devices, kits and methods are useful, e.g., for monitoring heparin therapy or diagnosing or monitoring mucopolysaccharidoses.
|
